Director Global Oncology Market Access - Alliances

The Director, Global Oncology Market Access - Alliances, will report to the Executive Director, oGMAx Alliances and lead global access and pricing strategy development and execution for new oncology pipeline assets across multiple indications. The role requires oncology market knowledge, understanding of the evolving global payer environment, and experience in market access, pricing, health outcomes, and launch preparation. The candidate must have strong project coordination, communication, and collaboration skills to lead cross-functional initiatives with commercial, clinical, regulatory, evidence generation, medical affairs, regional/local Access teams, and external alliance partners, while following established ways of working and legal/compliance requirements. Key deliverables include developing and executing the Global Plan for Access (GPA), supporting value implementation plans (V&I), and preparing access summaries for our company and alliance governance bodies. Additional deliverables include internal pricing strategy and forecasts aligned to the GPA and contract/legal terms, with clear communication to internal stakeholders and senior leaders. The selected candidate is expected to act with integrity, transparency, and strong values while adhering to applicable laws, regulations, and company policies. Key responsibilities may include but are not limited to the following: Lead the development and implementation of the market access & reimbursement strategy (including GPA) across all indications within assigned assets and partnering closely to develop key activities with V&I that support the strategy. Work closely with commercial asset/disease colleagues, respective tumor-level access colleagues, and Value & Implementation (V&I) Team/Center for Observational and Real-world Evidence (CORE) leads. Work closely with alliance partners with established Ways of Working and in compliance with alliance contract and legal constraints. Coordinate input into V&I with tumor access leads , and work with lead(s) from CORE, to provide market access input into evidence plan generation. Engaging with CORE on budget impact modeling and clinical economic models, when needed. Provide input on market access & reimbursement needs for new clinical trials, including launch indication considerations, and indication expansions. Coordinate with commercial colleagues to lead critical access pillars throughout commercial plans and senior management reviews, plan budgets and track commercial launch/competitive landscapes & clinical development progress. Engage with regional & local market access teams (especially US colleagues) to understand individual country market access & reimbursement needs ensuring these are included in asset Access strategies and V&I plans. Develop view on minimum level of clinical data needed from interim or final analyses to inform Go To File decisions. Lead payer market research to inform global asset access strategy and value dossier development. Competitive reimbursement tracking to inform on the impact of competitor reimbursement positions and tactics, which impact access/pricing strategies. Work with pricing colleagues to provide strategy awareness and support materials, as price responsibilities transition near launch.

Bachelors degree (BA or BS) in a business or science related discipline. 7 years experience, in Market Access, marketing, market research, pricing/ reimbursement, outcomes research or managed markets. Knowledgeable about product development and commercialization process Understanding of US and ex-US global payer environments and perspectives Proven success working within large and complex strategic initiatives Experience successfully leading cross functional matrix teams Strong financial and analytical skills Strong project management and implementation/operational skills Strong verbal and written communications skills Strong commercial orientation and business